KR19990001564A
(ko)
*
|
1997-06-16 |
1999-01-15 |
유충식 |
용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
|
KR100288890B1
(ko)
*
|
1997-12-31 |
2001-05-02 |
최현식 |
이트라코나졸 경구용 제제 및 그의 제조방법
|
PL191181B1
(pl)
|
1997-12-31 |
2006-03-31 |
Choongwae Pharma Corp |
Sposób wytwarzania doustnego preparatu itrakonazolu i doustny preparat itrakonazolu
|
KR100514330B1
(ko)
*
|
1997-12-31 |
2006-02-17 |
주식회사 중외제약 |
난용성 약물을 함유하는 코팅정
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
BR0009176A
(pt)
*
|
1999-03-24 |
2001-12-18 |
Fmc Corp |
Partìcula granular, forma de dosagem, métodopara preparar uma partìcula granular, misturaseca, e, formulação granular
|
KR100331529B1
(ko)
*
|
1999-06-16 |
2002-04-06 |
민경윤 |
난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
|
WO2001034119A2
(en)
|
1999-11-12 |
2001-05-17 |
Abbott Laboratories |
Inhibitors of crystallization in a solid dispersion
|
AU782469B2
(en)
*
|
1999-12-23 |
2005-08-04 |
Mayne Pharma International Pty Ltd |
Improved pharmaceutical compositions for poorly soluble drugs
|
FR2803748A1
(fr)
*
|
2000-01-14 |
2001-07-20 |
Ethypharm Lab Prod Ethiques |
Composition d'itraconazole et procede de preparation
|
DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
AU2001285768B2
(en)
*
|
2000-06-22 |
2005-03-10 |
Novartis Ag |
Solid valsartan pharmaceutical compositions
|
DE10038571A1
(de)
*
|
2000-08-03 |
2002-02-14 |
Knoll Ag |
Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
ES2275866T3
(es)
|
2001-02-14 |
2007-06-16 |
Tibotec Pharmaceuticals Ltd. |
2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
|
NZ528954A
(en)
|
2001-04-09 |
2005-04-29 |
Tibotec Pharm Ltd |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
|
ATE429431T1
(de)
|
2001-05-11 |
2009-05-15 |
Tibotec Pharm Ltd |
2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
|
WO2002100407A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Smartrix Technologies Inc. |
Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
|
EP1404300B1
(de)
|
2001-06-22 |
2009-09-30 |
Pfizer Products Inc. |
Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
|
KR100455216B1
(ko)
*
|
2001-06-27 |
2004-11-09 |
한미약품 주식회사 |
난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
|
US7163700B2
(en)
*
|
2001-07-31 |
2007-01-16 |
Capricorn Pharma, Inc. |
Amorphous drug beads
|
KR100438485B1
(ko)
*
|
2001-08-13 |
2004-07-09 |
한국디디에스제약 주식회사 |
아졸류 항진균제의 약제학적 조성물
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL160570A0
(en)
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
UA79248C2
(en)
|
2001-11-09 |
2007-06-11 |
Janssen Pharmaceutica Nv |
Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
|
CA2363376A1
(en)
*
|
2001-11-16 |
2003-05-16 |
Bernard Charles Sherman |
Solid pharmaceutical compositions for oral administration comprising itraconazole
|
US20040220240A1
(en)
*
|
2001-11-28 |
2004-11-04 |
Pellegrini Cara A. |
Method of increasing the extent of absorption of tizanidine
|
US6455557B1
(en)
*
|
2001-11-28 |
2002-09-24 |
Elan Pharmaceuticals, Inc. |
Method of reducing somnolence in patients treated with tizanidine
|
KR100942743B1
(ko)
|
2001-12-21 |
2010-02-16 |
티보텍 파마슈티칼즈 리미티드 |
광범위 스펙트럼 헤테로사이클릭 치환된 페닐 포함설폰아미드 hiv 프로테아제 저해제
|
HRP20020124A2
(en)
*
|
2002-02-11 |
2003-10-31 |
Pliva D D |
Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
|
MXPA04002602A
(es)
|
2002-02-28 |
2004-08-11 |
Japan Tobacco Inc |
Compuestos de ester y sus usos medicos.
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
JP4674084B2
(ja)
|
2002-05-17 |
2011-04-20 |
テイボテク・フアーマシユーチカルズ・リミテツド |
広域スペクトルの置換ベンズイソキサゾールスルホンアミドhivプロテアーゼ阻害剤
|
AU2003246351B2
(en)
*
|
2002-07-04 |
2009-02-19 |
Janssen Pharmaceutica N.V. |
Solid dispersions comprising two different polymer matrixes
|
MXPA05001792A
(es)
|
2002-08-14 |
2005-04-25 |
Tibotec Pharm Ltd |
Oxindolsulfonamida sustituida como inhibidores de proteasa de virus de inmunodeficiencia humana de amplio espectro.
|
AU2003270778B2
(en)
|
2002-09-20 |
2009-10-08 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
US20040086567A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Pawan Seth |
Bioequivalent composition of itraconazole and a hydrophilic polymer
|
SI1438961T2
(sl)
*
|
2003-01-14 |
2014-12-31 |
Cimex Pharma Ag |
Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
|
CA2509958A1
(en)
*
|
2003-02-03 |
2004-08-19 |
Novartis Ag |
Pharmaceutical formulation
|
WO2005011702A1
(en)
*
|
2003-07-17 |
2005-02-10 |
Tibotec Pharmaceuticals Ltd. |
Process for preparing particles containing an antiviral
|
FR2857591B1
(fr)
*
|
2003-07-17 |
2007-11-02 |
Ethypharm Sa |
Particules comprenant un principe actif sous forme de co-precipite
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
WO2005021486A1
(ja)
|
2003-08-29 |
2005-03-10 |
Japan Tobacco Inc. |
エステル誘導体及びその医薬用途
|
US20050058670A1
(en)
*
|
2003-09-09 |
2005-03-17 |
Jong-Soo Woo |
Oral itraconazole composition which is not affected by ingested food and process for preparing same
|
BRPI0414199A
(pt)
|
2003-09-11 |
2006-10-31 |
Tibotec Pharm Ltd |
inibidores de entrada do vìrus hiv
|
US20050118265A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Anandi Krishnan |
Antifungal oral dosage forms and the methods for preparation
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
US20050249799A1
(en)
*
|
2004-03-03 |
2005-11-10 |
Spherics, Inc. |
Polymeric drug delivery system for hydrophobic drugs
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
EP2422780A1
(de)
|
2004-05-07 |
2012-02-29 |
Sequoia Pharmaceuticals, Inc. |
Resistenzabweisende retrovirale Proteaseinhibitoren
|
JP4879889B2
(ja)
|
2004-05-17 |
2012-02-22 |
テイボテク・フアーマシユーチカルズ・リミテツド |
4−置換−1,5−ジヒドロ−ピリド[3,2−b]インドール−2−オン
|
CN1976930B
(zh)
|
2004-05-17 |
2011-01-19 |
泰博特克药品有限公司 |
用作抗感染药物的6,7,8,9-取代的1-苯基-1,5-二氢吡啶并(3,2-b)吲哚-2-酮
|
CN1953983B
(zh)
|
2004-05-17 |
2010-05-26 |
泰博特克药品有限公司 |
1-杂环基-1,5-二氢-吡啶并[3,2-b]吲哚-2-酮
|
WO2005117834A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Janssen Pharmaceutica N.V. |
Solid dispersions of a basic drug compound and a polymer containing acidic groups
|
KR20050119397A
(ko)
*
|
2004-06-16 |
2005-12-21 |
보람제약주식회사 |
고상용해를 이용한 난용성 약물의 가용화 방법과 이를이용한 가용화 조성물
|
US20060030623A1
(en)
*
|
2004-07-16 |
2006-02-09 |
Noboru Furukawa |
Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
|
KR100708974B1
(ko)
*
|
2004-07-19 |
2007-04-18 |
주식회사종근당 |
수용성 수지를 이용한 이트라코나졸 고체분산체
|
US20070281007A1
(en)
*
|
2004-08-27 |
2007-12-06 |
Jacob Jules S |
Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
US8101774B2
(en)
*
|
2004-10-18 |
2012-01-24 |
Japan Tobacco Inc. |
Ester derivatives and medicinal use thereof
|
BRPI0516772A
(pt)
*
|
2004-10-25 |
2008-09-23 |
Japan Tobacco Inc |
formulação sólida com solubilidade e estabilidade melhoradas e método para produção da referida formulação
|
US9504658B2
(en)
|
2004-11-09 |
2016-11-29 |
Board Of Regents, The University Of Texas System |
Stabilized HME composition with small drug particles
|
US8604055B2
(en)
|
2004-12-31 |
2013-12-10 |
Dr. Reddy's Laboratories Ltd. |
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
|
DK1848430T3
(da)
|
2004-12-31 |
2017-11-06 |
Dr Reddys Laboratories Ltd |
Nye benzylamin-derivativer som cetp-inhibitors
|
AR056652A1
(es)
|
2005-04-11 |
2007-10-17 |
Tibotec Pharm Ltd |
Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
|
DE102005026755A1
(de)
*
|
2005-06-09 |
2006-12-14 |
Basf Ag |
Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
|
US8486456B2
(en)
|
2005-08-08 |
2013-07-16 |
Abbott Gmbh & Co., Kg |
Itraconazole compositions with improved bioavailability
|
US20090028938A1
(en)
*
|
2005-08-08 |
2009-01-29 |
Abbott Gmbh & Co. Kg |
Dosage forms with improved bioavailability
|
WO2007024971A2
(en)
|
2005-08-22 |
2007-03-01 |
The Johns Hopkins University |
Hedgehog pathway antagonists to treat disease
|
JP2009527504A
(ja)
*
|
2006-02-23 |
2009-07-30 |
イオメディックス スリープ インターナショナル エスアールエル |
良質な睡眠の誘導および維持のための組成物および方法
|
JP2009534311A
(ja)
|
2006-04-03 |
2009-09-24 |
テイボテク・フアーマシユーチカルズ・リミテツド |
HIV阻害性3,4−ジヒドロ−イミダゾ[4,5−b]ピリジン−5−オン
|
GB0607105D0
(en)
*
|
2006-04-10 |
2006-05-17 |
Leuven K U Res & Dev |
Enhancing solubility and dissolution rate of poorly soluble drugs
|
HUE032156T2
(en)
|
2006-06-19 |
2017-09-28 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical preparations
|
WO2008013416A1
(en)
*
|
2006-07-27 |
2008-01-31 |
Amorepacific Corporation |
Process for preparing powder comprising nanoparticles of sparingly soluble drug
|
EP2073797A2
(de)
*
|
2006-10-11 |
2009-07-01 |
Alpharma, Inc. |
Pharmazeutische zusammensetzungen
|
CN101702878B
(zh)
*
|
2007-05-11 |
2012-11-28 |
弗·哈夫曼-拉罗切有限公司 |
可溶性差的药物的药物组合物
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8486423B2
(en)
*
|
2007-08-21 |
2013-07-16 |
Board Of Regents, The University Of Texas System |
Thermo-kinetic mixing for pharmaceutical applications
|
ES2560899T3
(es)
|
2007-09-14 |
2016-02-23 |
Wockhardt Limited |
Composiciones de diacereína
|
EP2520283A1
(de)
|
2007-09-27 |
2012-11-07 |
Wockhardt Limited |
Pharmazeutische Zusammensetzungen von Rhein oder Diacerin
|
US20090130160A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Fiber Innovation Technology, Inc. |
Fiber for wound dressing
|
EP2224923A4
(de)
|
2007-11-28 |
2013-05-15 |
Sequoia Pharmaceuticals Inc |
Zusammensetzungen und verfahren zur hemmung von zytochrom p450 2d6
|
EP2224805A4
(de)
*
|
2007-12-17 |
2013-10-16 |
Alpharma Pharmaceuticals Llc |
Pharmazeutische zusammensetzung
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
AU2009203627A1
(en)
*
|
2008-01-11 |
2009-07-16 |
Cipla Limited |
Solid pharmaceutical dosage form
|
EP2257160B1
(de)
|
2008-02-21 |
2017-07-05 |
Sequoia Pharmaceuticals, Inc. |
Diamidhemmer von cytochrom p450
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
CN102105136B
(zh)
|
2008-03-11 |
2014-11-26 |
蒂宝制药公司 |
包含非-阿片类止痛剂和阿片类止痛剂的组合的胃滞留型缓释剂型
|
NZ588460A
(en)
*
|
2008-04-15 |
2012-07-27 |
Schering Corp |
Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
|
EA200900145A1
(ru)
*
|
2008-12-31 |
2010-02-26 |
Открытое Акционерное Общество "Верофарм" |
Противогрибковое средство для вагинального применения
|
CN101780046B
(zh)
*
|
2009-01-16 |
2011-09-21 |
北京化工大学 |
一种伊曲康唑复合粉体及其制备方法
|
ES2453477T3
(es)
|
2009-12-18 |
2014-04-07 |
Frieslandcampina Nederland Holding B.V. |
Composición de excipiente coprocesada para un comprimido, su preparación y uso
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US20130303628A1
(en)
*
|
2010-10-14 |
2013-11-14 |
Abbott Laboratories |
Curcuminoid solid dispersion formulation
|
CN102068416A
(zh)
*
|
2010-12-30 |
2011-05-25 |
安徽先求药业有限公司 |
一种含有伊曲康唑的口服固体制剂及其制备方法
|
CA2824639A1
(en)
|
2011-02-17 |
2012-08-23 |
Ashish Chatterji |
A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
|
US9050335B1
(en)
|
2011-05-17 |
2015-06-09 |
Mallinckrodt Llc |
Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
IN2014CN00827A
(de)
*
|
2011-08-16 |
2015-04-03 |
Merck Sharp & Dohme |
|
JP5964965B2
(ja)
|
2011-08-18 |
2016-08-03 |
ドクター レディズ ラボラトリーズ リミテッド |
コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物
|
WO2013037396A1
(en)
*
|
2011-09-12 |
2013-03-21 |
Bioneer A/S |
Solution of polymer in api for a solid dosage form
|
WO2013046045A1
(en)
|
2011-09-27 |
2013-04-04 |
Dr. Reddy's Laboratories, Ltd. |
5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
|
US20140128431A1
(en)
|
2012-04-03 |
2014-05-08 |
Hoffmann-Laroche Inc. |
Pharmaceutical composition with improved bioavailability, safety and tolerability
|
EP2649989B1
(de)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Verfahren zur Herstellung einer Feststoffdispersion, damit hergestellte Feststoffdispersion und Verwendung dafür
|
BR112014031706A8
(pt)
|
2012-06-21 |
2021-10-19 |
Mayne Pharma Int Pty Ltd |
Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
|
EP2874607B1
(de)
|
2012-07-17 |
2017-05-31 |
Dow Global Technologies LLC |
Feste dispersion mit hochsubstituierter hydroxyalkyl-methylcellulose
|
EP2919765A2
(de)
|
2012-11-19 |
2015-09-23 |
Dr. Reddy's Laboratories Ltd. |
Pharmazeutische cetp-inhibitorzusammensetzungen
|
EP2948141A1
(de)
|
2013-01-22 |
2015-12-02 |
F. Hoffmann-La Roche AG |
Pharmazeutische zusammensetzung mit verbesserter bioverfügbarkeit
|
CN104721827A
(zh)
*
|
2013-12-18 |
2015-06-24 |
博瑞生物医药技术(苏州)有限公司 |
一种难溶性抗真菌药物固体分散体及其制备方法
|
CN105873954B
(zh)
|
2014-01-16 |
2019-03-29 |
陶氏环球技术有限责任公司 |
用于3d打印的支撑材料
|
JP6810060B2
(ja)
*
|
2015-06-09 |
2021-01-06 |
ダウ グローバル テクノロジーズ エルエルシー |
3d印刷用支持材料
|
EP3454847A4
(de)
*
|
2016-05-09 |
2019-12-18 |
Dispersol Technologies, LLC |
Verbesserte arzneimittelformulierungen
|
WO2019043427A1
(en)
|
2017-09-01 |
2019-03-07 |
Jordan Sweden Medical And Sterilization Company |
FAST SELF-DISPERSION DOSAGE FORMS OF DEFERASIROX
|
CN109172532A
(zh)
*
|
2018-10-24 |
2019-01-11 |
北京哈三联科技有限责任公司 |
一种伊曲康唑分散片及其制备方法和应用
|
WO2021041824A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Lubrizol Advanced Materials, Inc. |
Drug-polymer amorphous solid dispersions using linear poly (acrylic acid) polymers
|
KR102266145B1
(ko)
*
|
2019-09-26 |
2021-06-17 |
대봉엘에스 주식회사 |
비정질 에피나코나졸 고체 분산체
|
WO2023025672A1
(en)
|
2021-08-25 |
2023-03-02 |
Basf Se |
Direct tableting auxiliary composition
|